Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3006

Actual shortage: 230 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2747 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-10 2017-04-01 384
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-08-31 16942
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-10 28553
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-19 2019-07-17 70146
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-04 2020-08-17 116542
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137261
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137264
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-07 2021-07-02 138963
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-21 2021-10-28 145949
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-22 159722
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-26 214241
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-01 2024-03-22 221096
APO-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2018-12-05 2018-12-19 68725
APO-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2019-07-03 2020-01-06 88371
APO-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2022-03-15 2022-05-19 156762
APO-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2023-07-07 2023-09-01 197884
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2017-07-25 2018-03-08 16886
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971

Showing 1921 to 1940 of 3006

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-FUROSEMIDE 80MG TABLET Discontinued 2017-03-30 2018-02-05 4719
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-ATORVASTATIN 80MG TABLET Discontinued 2018-09-07 2018-12-29 60285
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-ASA LD 81MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60252
COATED DAILY LOW DOSE ASA 81 MG 81MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-04 71083
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977

Showing 341 to 356 of 356